Quick Links

Impact of immunosenescence on transplant outcome.

Authors: Timm Heinbokel|||Karin Hock|||Guangxiang Liu|||Karoline Edtinger|||Abdallah Elkhal|||Stefan G Tullius

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Publication Type: Comparative Study

Date: 2013

DOI: 10.1111/tri.12013

ID: 23190423

Affiliations:

Affiliations

    Transplant Surgery Research Laboratory and Division of Transplant Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.|||||||||||||||

Abstract

Aging affects all compartments of the immune response and has a major impact on transplant outcome and organ quality. Although clinical trials in the aging transplant population remain rare, our current understanding of immunosenescence provides a basis for an age-adapted immunosuppression and organ allocation with the goal to optimize utilization and to improve outcomes in older recipients. From a more general perspective, understanding the mechanisms and consequences of immunosenescence will have a broad impact on immune therapies in and beyond transplantation.